GLOBAL VETERINARY VACCINES MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • GLOBAL VETERINARY VACCINES MARKET FORECAST 2020-2028

GLOBAL VETERINARY VACCINES MARKET FORECAST 2020-2028

The global veterinary vaccine market is anticipated to grow at a CAGR of 5.88% between 2020 and 2028 and is anticipated to generate revenue of $12.02 billion by 2028. The veterinary vaccines market is expected to be driven by innovations in vaccines, growing awareness of animal health, increasing investments by government associations, and rising demand for milk, including animal protein meat, fish, eggs, and increased spending on the healthcare of companion animals.

GLOBAL VETERINARY VACCINES MARKET FORECAST 2020-2028

Global Veterinary Vaccines Market by Vaccine Type (Livestock Vaccine (Porcine Vaccine, Bovine Vaccine, Poultry Vaccine, Aquaculture Vaccine, Other Livestock Vaccine), Companion Vaccine (Canine Vaccine, Feline Vaccine, Equine Vaccine)) by Technology (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, Toxoid Vaccine, Other Technology) by Disease (Canine Disease, Porcine Disease, Bovine Disease, Poultry Disease, Aquaculture Disease, Other Disease Type) by Geography.

Request free sample

The global veterinary vaccines market is anticipated to grow at a CAGR of 5.88% between 2020 and 2028 and is anticipated to generate revenue of $12.02 billion by 2028. The veterinary vaccines market is expected to be driven by innovations in vaccines, growing awareness of animal health, increasing investments by government associations, and rising demand for milk, including animal protein meat, fish, eggs, and increased spending on the healthcare of companion animals.

The global veterinary vaccines market is driven by the following factors:

  • Progression in the vaccine products
  • Increasing government initiatives
  • Increasing incidence of zoonotic diseases
  • A surge in the companion animal ownership
  • Growing prevalence of livestock diseases

The important drivers increasing growth in the global veterinary vaccines market are increasing vaccine products and surging companion animal ownership. Immense progress takes place in the management of animal health via vaccination. There are research organizations and animal healthcare companies that work to ensure the good health of animals. Growth in the momentum of pet ownership by old people is seen in recent years, especially in developed countries.

In 2019, around 22.23% of revenue share was captured by the canine disease segment in terms of the veterinary vaccine disease type, as well as is anticipated to be the fastest-growing application. Canine rabies is fatal viral polio encephalitis, which specifically affects the gray matter of a dog’s brain along with the central nervous system (CNS). The disease is an emerging threat to public health due to rabid dogs bite humans, causing thousands of deaths every year. Also, porcine disease constitutes the second largest market share. The segment porcine disease covers porcine reproductive and respiratory syndrome, diseases associated with porcine circovirus II, swine influenza, and others.

The high cost of vaccinations and side effects associated with veterinary vaccines on human and animal health are the major factors hindering the veterinary vaccine market analysis. The high storage costs are acting as chief restraint by further restraining the development of the veterinary vaccines market. Vaccines may lose their effectiveness if they become too hot or too cold at any time. Common adverse effects post-vaccination include anaphylaxis, systemic reaction, autoimmune hemolytic anemia, respiratory disease, and post-vaccination sarcoma.

The report on the global veterinary vaccines market includes segmentation on the basis of vaccine type, technology, and disease type.

Vaccine type is segmented into:

  • Livestock vaccine
    • Porcine vaccine
    • Bovine vaccine
    • Poultry vaccine
    • Aquaculture vaccine
    • Other livestock vaccine
  • Companion vaccine
    • Canine vaccine
    • Feline vaccine
    • Equine vaccine

Technology is segmented into:

  • Live attenuated vaccine
  • Inactivated vaccine
  • Recombinant vaccine
  • Toxoid vaccine
  • Other technology

Disease Type is segmented into:

  • Canine disease
  • Porcine disease
  • Bovine disease
  • Poultry disease
  • Aquaculture disease
  • Other disease types

Geographically, the global veterinary vaccines market has been segmented on the basis of four major regions, which includes:

  • North America: The United States and Canada
  • Europe: Germany, the United Kingdom, Italy, Russia, France, Belgium, Poland, and Rest of Europe
  • Asia Pacific: China, Thailand, Indonesia, India, South Korea, Japan, Vietnam, Australia & New Zealand, and Rest of Asia Pacific
  • Rest of World: Latin America, the Middle East & Africa

In 2019, North America captured the largest market share of about 40.14%, in terms of revenue, which is estimated to continue towards the end of the forecast period. The US dominates the North American market region in terms of revenue share, which is attributed to factors like awareness regarding the prevention of animal to human transmission diseases and safe animal food supply.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region. Developing economies have witnessed an expansion in the pet care industry. For example, the Indian pet care industry has experienced progressive growth due to an increase in awareness about pet health and pet care products. The number of pets adopted every year is on the increase, which is approximately 600,000 pets.

The prominent market players of the global veterinary vaccines market are:

  • Boehringer Ingelheim Animal Health Gmbh
  • Elanco (Eli Lilly And Company)
  • Ceva Sante Animale
  • Phibro Animal Health Corp.
  • Merck & Co.
  • Others

Key strategies adopted by some of the veterinary vaccines companies are:

In January 2020, Boehringer Ingelheim partnered with Enleofen to develop First-in-Class Anti-IL-11 therapies for a range of Fibrotic diseases. In September 2019, Ceva partnered with biotecon diagnostics to introduce a real-time test kit to fight the growing problem of salmonella on pig farms.

Key findings of the global veterinary vaccines market include:

  • Livestock vaccine type is the highest revenue-generating segment.
  • Recombinant vaccine is the fastest-growing veterinary vaccine technology.
  • The canine disease is the most predominant disease type.
  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARIES
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    • KEY DRIVERS
      • PROGRESSION IN THE VACCINE PRODUCTS
      • INCREASING GOVERNMENT INITIATIVES
      • INCREASING INCIDENCE OF ZOONOTIC DISEASES
      • SURGE IN THE COMPANION ANIMAL OWNERSHIP
      • GROWING PREVALENCE OF LIVESTOCK DISEASES
    • KEY RESTRAINTS
      • HIGH COST OF VACCINATIONS
      • SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      • LACK OF SKILLED FARMWORKERS AND VETERINARIANS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPANY PROFILES
    • ANICON LABOR GMBH
    • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    • CEVA SANTE ANIMALE
    • ELANCO (ELI LILLY AND COMPANY)
    • HESTER BIOSCIENCES LIMITED
    • HIPRA
    • HYGIEIA BIOLOGICAL LABORATORIES
    • MERCK & CO.
    • PHIBRO ANIMAL HEALTH CORP.
    • ROMVAC COMPANY S.A.
    • VAXXINOVA GMBH-GERMANY
    • VIRBAC SA
    • ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE

TABLE 2: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: GLOBAL LIVESTOCK VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: GLOBAL LIVESTOCK VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: GLOBAL LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: GLOBAL LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: GLOBAL PORCINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 10: GLOBAL PORCINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 11: GLOBAL BOVINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES

TABLE 13: GLOBAL BOVINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 14: GLOBAL POULTRY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES

TABLE 16: GLOBAL POULTRY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 17: GLOBAL AQUACULTURE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES

TABLE 19: GLOBAL AQUACULTURE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 20: GLOBAL OTHER LIVESTOCK VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: GLOBAL OTHER LIVESTOCK VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 22: GLOBAL COMPANION VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: GLOBAL COMPANION VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 24: GLOBAL COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: GLOBAL COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 26: GLOBAL CANINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 28: GLOBAL CANINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 29: GLOBAL FELINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 31: GLOBAL FELINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 32: GLOBAL EQUINE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 34: GLOBAL EQUINE VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 35: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 36: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 37: GLOBAL LIVE ATTENUATED VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 38: GLOBAL LIVE ATTENUATED VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 39: GLOBAL INACTIVATED VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 40: GLOBAL INACTIVATED VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 41: GLOBAL RECOMBINANT VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 42: GLOBAL RECOMBINANT VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 43: GLOBAL TOXOID VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 44: GLOBAL TOXOID VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 45: GLOBAL OTHER TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 46: GLOBAL OTHER TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 47: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 48: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 49: GLOBAL CANINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 50: GLOBAL CANINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 51: GLOBAL PORCINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 52: GLOBAL PORCINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 53: GLOBAL BOVINE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 54: GLOBAL BOVINE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 55: GLOBAL POULTRY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 56: GLOBAL POULTRY DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 57: GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 58: GLOBAL AQUACULTURE DISEASE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 59: GLOBAL OTHER DISEASE TYPE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 60: GLOBAL OTHER DISEASE TYPE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 61: GLOBAL VETERINARY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 62: GLOBAL VETERINARY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 63: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 64: NORTH AMERICA VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 65: EUROPE VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 66: EUROPE VETERINARY VACCINE, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 67: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 68: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 69: REST OF WORLD VETERINARY VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 70: REST OF WORLD VETERINARY VACCINE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

FIGURE LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: GLOBAL VETERINARY VACCINES, BY VACCINE TYPE, IN 2019

FIGURE 5: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 6: GLOBAL LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 7: GLOBAL LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 8: GLOBAL LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 9: GLOBAL LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 10: GLOBAL LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 11: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 12: GLOBAL COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 13: GLOBAL COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 14: GLOBAL COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 15: GLOBAL VETERINARY VACCINES, BY TECHNOLOGY, IN 2019

FIGURE 16: GLOBAL VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 17: GLOBAL VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 18: GLOBAL VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 19: GLOBAL VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)

FIGURE 20: GLOBAL VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 21: GLOBAL VETERINARY VACCINES, BY DISEASE TYPE, IN 2019

FIGURE 22: GLOBAL VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 23: GLOBAL VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 24: GLOBAL VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 25: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 26: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 27: GLOBAL VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 29: THE UNITED STATES VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 30: CANADA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 31: EUROPE VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 32: THE UNITED KINGDOM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 33: FRANCE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 34: GERMANY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 35: ITALY VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 36: RUSSIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 37: BELGIUM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 38: POLAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 39: REST OF EUROPE VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 40: ASIA PACIFIC VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 41: CHINA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 42: JAPAN VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 43: INDIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 44: AUSTRALIA & NEW ZEALAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 45: SOUTH KOREA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 46: THAILAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 47: INDONESIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 48: VIETNAM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 49: REST OF ASIA PACIFIC VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 50: REST OF WORLD VETERINARY VACCINE MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 51: LATIN AMERICA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

FIGURE 52: MIDDLE EAST & AFRICA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)

  1. MARKET BY VACCINE TYPE
    • LIVESTOCK VACCINE
      • PORCINE VACCINE
      • BOVINE VACCINE
      • POULTRY VACCINE
      • AQUACULTURE VACCINE
      • OTHER LIVESTOCK VACCINE
    • COMPANION VACCINE
      • CANINE VACCINE
      • FELINE VACCINE
      • EQUINE VACCINE
  1. MARKET BY TECHNOLOGY
    • LIVE ATTENUATED VACCINE
    • INACTIVATED VACCINE
    • RECOMBINANT VACCINE
    • TOXOID VACCINE
    • OTHER TECHNOLOGY
  2. MARKET BY DISEASE TYPE
    • CANINE DISEASE
    • PORCINE DISEASE
    • BOVINE DISEASE
    • POULTRY DISEASE
    • AQUACULTURE DISEASE
    • OTHER DISEASE TYPE
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • AUSTRALIA & NEW ZEALAND
      • SOUTH KOREA
      • THAILAND
      • INDONESIA
      • VIETNAM
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now